BIOLINE RX revenue for the last year amounted to 17.43 M ILS, the most of which — 17.00 M ILS — came from its highest performing source at the moment, License. The greatest contribution to the revenue figure was made by Israel — last year it brought BIOLINE RX 17.70 M ILS, and the year before that — 113.16 M ILS.